Ashraf Hanna, Director at Nexvet Biopharma plc (NVET), bought 1,500 shares at $3.20 ($5K) on 2016-03-02, disclosed to the SEC on 2016-03-03.
Open-market purchase of $5k NVET by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.